General Information
- HIV and Kidney Disease (AIDS InfoNet) and Spanish version
- The Kidneys (AIDSmap)
- Kidney Disease Tests (labtestsonline) – page with links to fact sheets on the many types of tests used to monitor the function of the kidneys and urinary tract
Selected Recent Articles
- Three Non-AIDS Illnesses Tied to Cognitive Impairment in Men with HIV. (September 2016, TheBodyPro)
- For Injection Drug Users With HIV, Higher Risk of Liver/Kidney Disease — But Not Other Non-AIDS Ills. (August 2016, TheBodyPro)
- Kidney and Bone Markers Improve in Patients With Renal Impairment After Switch from TDF to TAF. (August 2016, TheBodyPro)
- Poor kidney function associated with increased cardiovascular risk for people with HIV. (August 2016, AIDSmap)
- Slow But Steady Increase in Kidney Risk Observed With TDF, Atazanavir, Lopinavir. (August 2016, TheBodyPro)
- Kidney Function Better Over 2 Years With Immediate ART in START Trial. (August 2016, TheBodyPro)
- Bone loss partially recovers after stopping PrEP, twice-yearly kidney monitoring is enough for most. (July 2016, AIDSmap)
- Studies examine switch to TAF-based regimens in patients with renal impairment. (July 2016, Healio)
- Starting Treatment With First-Line Protease Inhibitors May Increase Kidney Disease Risk. (July 2016, TheBodyPro)
- Switching from tenofovir DF to TAF improves bone and kidney safety. (July 2016, AIDSmap)
- TAF-based regimen demonstrates safety, efficacy in patients with diabetes, renal impairment. (June 2016, Healio)
- New Tenofovir Easy on the Kidneys. (June 2016, Medpage Today)
- Tenofovir alafenamide works well against hepatitis B with less effect on bones and kidneys. (April 2016, AIDSmap)
- Serious kidney problems are rare with PrEP, but increase with older age and better adherence. (April 2016, Project Inform)
- Hepatitis C Cure is Linked to Lowered Risk of Death, Kidney Disease and Diabetes in Those With HIV. (March 2016, Poz)
- Does Hep C Exposure Raise the Risk of Kidney Disease and Osteoporosis in People With HIV? (March 2016, Poz)
- Frequent Cocaine Injection Among people with HIV and Hepatitis C Raises the Risk of Chronic Kidney Impairment. (March 2016, Poz)
- Switching to emtricitabine/tenofovir alafenamide (F/TAF) maintains viral suppression with better bone and kidney safety. (February 2016, TheBody); related coverage from Project Inform
- Truvada as PrEP against HIV leads to modest decline in kidney function (Poz); related coverage from AIDSmap, Beta Blog, and in CROI abstract 1 and abstract 2
- HIV Meds Can Cause Cumulative Reduction in Kidney Function. (December 2015, Poz)
- Tenofovir alafenamide single-tablet regimen shows good efficacy with improved kidney and bone safety. (October 2015, AIDSmap)
- Inflammation Markers Tied to Worse Kidney Function in Men Taking Antiretroviral Therapy. (October 2015, TheBodyPro)
- Single-Tablet HIV Regimen Containing Tenofovir Alafenamide Improves Bone and Kidney Safety. (September 2015, TheBodyPro)
- Updated Tenofovir Is Safer for Bones and Kidneys. (July 2015, Poz)
- Switching to new tenofovir alafenamide keeps virus in check and improves kidney and bone health. (July 2015, AIDSmap)
- Lower daily tenofovir dose of 150mg safe and effective in people with moderate renal impairment. (May 2015, AIDSmap)
- Merck’s Hep C Therapy Cures 99% of Those with Kidney Disease. (April 2015, Hepmag)
- New form of tenofovir TAF looks to be easier on bone and kidney health to the current TDF. (March 2015, Project Inform)
- The Kidney at CROI 2015. (March 2015, NATAP)
- Several HIV Meds Steadily Raise Kidney Disease Risk Over Time. (March 2015, Poz)
- Tenofovir, boosted atazanavir and boosted lopinavir are associated with cumulative risk of developing chronic kidney disease.
(February 2015, AIDSmap) - Tenofovir alafenamide equally effective but safer for kidneys and bones than current formulation. (February 2015, AIDSmap)
- Exposure to antiretrovirals and development of chronic kidney disease – D:A:D Study Group. (February 2015, NATAP)
- Poor kidney function predicts neurocognitive decline with undetectable viral load. (February 2015, NATAP)
- Patients with HIV can safely receive kidneys from deceased HIV-positive donors, with good five-year survival rates. (February 2015, AIDSmap)
- Kidneys From Donors With HIV Transplant Well Into HIV-Positive Recipients. (February 2015, Poz)
- Age-Related Diseases Not Occurring Earlier for People With HIV. (November 2014, Poz)
- Long-Term Tenofovir Use Associated With Higher Rates of Kidney Problems. (November 2014, TheBodyPro)
- Cobicistat Safe for HIV-Positive Patients with Mild to Moderate Renal Impairment. (October 2014, TheBody)
- People With HIV and Kidney Problems Should Avoid Viread (Tenofovir) (October 2014, Poz)
- U.S. HIV guidelines for management of chronic kidney disease. (September/October 2014, HIV Treatment Bulletin)
- HIV infection associated with an increased risk of the diseases of ageing. (September 2014, AIDSmap)
- Guidelines Advise Against Tenofovir for HIV Patients With Kidney Disease. (September 2014, TheBodyPro)
- Tenofovir Tied to Kidney Damage in Those With Low Body Weight. (September 2014, Poz)
- Tenofovir HIV PrEP causes no long-term harm to kidneys. (May 2014, AIDSmap)
- New Kidney Risk Score System May Guide HIV Med Choices. (April 2014, Poz)
- Risk score can help predict which people living with HIV have highest risk of kidney disease during tenofovir treatment. (March 2014, AIDSmap)
- Stopping TDF Before Renal Impairment Boosts Chance of Improving eGFR. (March 2014, NATAP)
- Truvada as PrEP Appears Not to Damage Kidneys. (February 2014, Poz)
- Truvada PrEP does not harm the kidneys, trial shows. (February 2014, AIDSmap)
- New Tenofovir Has Lower Dose, Is Kinder to Kidneys and Bones. (September 2013, Poz)
- New tenofovir formulation works equally well with less effect on kidneys and bones. (September 2013, AIDSmap)
- Loss of kidney function in older people with HIV underlines need for earlier treatment. (September 2013, AIDSmap)
- First Kidney Transplant Between People With HIV Is a Success. (August 2013, Poz)
- Cleared HCV infection associated with increased risk of kidney disease in people with HIV. (August 2013, AIDSmap)
- People With HIV Have High Rates of End-Stage Renal Disease. (July 2013, Poz)
- Kidney problems linked to tenofovir use, improve with switch to abacavir. (July 2013, AIDSmap)
- The Kidney at CROI 2013. (March 2013, NATAP)
- Cardiovascular Disease and Co-morbidities in HIV. (March 2013, NATAP)
- HIV-Infected Adults Are at Greater Risk for Myocardial Infarction (MI), End-stage Renal Disease (ESRD), and Non-AIDS-defining Cancers, But Events Occur at Similar Ages Compared to HIV-uninfected Adults (VA) (March 2013, NATAP)
- New Tenofovir Prodrug Shows Potency, Plus Better Kidney and Bone Safety Than Current Formulation. (March 2013, TheBodyPro)
- New tenofovir prodrug virologically equivalent to TDF – and easier on kidneys and bone. (March 2013, NATAP)
- Higher MI, ESRD, Cancer Rates With HIV – But Not Necessarily at Younger Age. (March 2013, NATAP)
- Tenofovir, atazanavir/ritonavir and Kaletra associated with kidney problems in patients taking HIV therapy. (February 2013, AIDSmap)
- Tenofovir May Raise Risk of Kidney Damage, but Effect Tapers Over Time. (February 2013, Poz)
- Conditions Outside of AIDS Pose Significant Threat to People With HIV. (January 2013, Poz)